PDF
Abstract
Aim: Paxillin is a well-known multidomain scaffold protein that is involved in the regulation of cell-matrix adhesion dynamics, a process required for the tumor cell migration and invasion. Phosphorylation of the serine residue 178 requires c-Jun NH2-terminal kinase (JNK) activation, which occurs downstream of epidermal growth factor receptor (EGFR)-mediated signaling and drives cell migration. In this study, we investigated the significance of paxillin Ser178 phosphorylation in breast cancer progression.
Methods: We employed the rat mammary carcinoma MTLn3 cell line with which we established stabile variants of both wild type and mutant GFP-paxillin constructs. With those, we next performed several in vitro assays including cell proliferation, migration and focal adhesion dynamics. Finally, we monitored the metastatic spread of both cell line variants in an othrotopic mouse model for breast cancer.
Results: Here we show that expression of the phospho-defective mutant paxillinS178A in the metastatic mammary adenocarcinoma MTLn3 cell-line significantly decreased EGF-induced cell migration, which was correlated with impaired focal adhesion dynamics. Moreover, paxillinS178A attenuated lung metastasis formation in an orthotopic In vivo mammary gland tumor/metastasis model, demonstrating the importance of JNK-mediated paxillin phosphorylation in breast cancer progression. Expression of paxillinS178A caused a decrease in EGFR expression, while re-expression of EGFR in MTLn3-paxillinS178A cells fully restored EGF-driven cell motility and focal adhesion dynamics. Furthermore, re-expression of EGFR in MTLn3-paxillinS178A rescued spontaneous metastasis from breast to lung.
Conclusion: Overall our data show an important role for JNK-mediated paxillin Ser178 phosphorylation in the regulation of EGFR expression and thereby, in EGF-driven cell migration and metastasis formation.
Keywords
Paxillin
/
c-Jun NH2-terminal kinase
/
focal adhesion
/
epidermal growth factor receptor
/
cell migration
/
metastasis
/
breast cancer
Cite this article
Download citation ▾
Saertje Verkoeijen, Ya-Feng Ma, Wies van Roosmalen, Reshma Lalai, Martine H. A. M. van Miltenburg, Marjo de Graauw, Bob van de Water, Sylvia E. Le Dévédec.
Paxillin serine 178 phosphorylation in control of cell migration and metastasis formation through regulation of EGFR expression in breast cancer.
Journal of Cancer Metastasis and Treatment, 2019, 5: 51 DOI:10.20517/2394-4722.2019.06
| [1] |
Pantel K.Dissecting the metastatic cascade..Nat Rev Cancer2004;4:448-56
|
| [2] |
Steeg PS.Targeting metastasis..Nat Rev Cancer2016;16:201-18
|
| [3] |
Fidler IJ.The challenge of targeting metastasis..Cancer Metastasis Rev2015;34:635-41 PMCID:PMC4661188
|
| [4] |
Hamidi H.Every step of the way: integrins in cancer progression and metastasis..Nat Rev Cancer2018;18:533-48
|
| [5] |
Nguyen DX,Massague J.Metastasis: from dissemination to organ-specific colonization..Nat Rev Cancer2009;9:274-84
|
| [6] |
Sethi N.Unravelling the complexity of metastasis - molecular understanding and targeted therapies..Nat Rev Cancer2011;11:735-48
|
| [7] |
Huang C,Schaller MD.A role for JNK-paxillin signaling in cell migration..Cell Cycle2004;3:4-6
|
| [8] |
Huang C,Schaller MD.MAP kinases and cell migration..J Cell Sci2004;117:4619-28
|
| [9] |
Huang Z,Ge BX.JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin..Cell Signal2008;20:2002-12
|
| [10] |
Le Devedec SE,Maria N,Pont C.An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse..Clin Exp Metastasis2009;26:673-84 PMCID:PMC2776159
|
| [11] |
Omran OM.Cytoskeletal focal adhesion proteins fascin-1 and paxillin are predictors of malignant progression and poor prognosis in human breast cancer..J Environ Pathol Toxicol Oncol2015;34:201-12
|
| [12] |
Wagner EF.Signal integration by JNK and p38 MAPK pathways in cancer development..Nat Rev Cancer2009;9:537-49
|
| [13] |
Chen J.MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis..Cancer Res2012;72:4130-40
|
| [14] |
Shin EY,Kim EG.c-Jun N-terminal kinase is involved in motility of endothelial cell..Exp Mol Med2001;33:276-83
|
| [15] |
Xia Y,Su B,Yang J.MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration..Proc Natl Acad Sci U S A.2000;97:5243-8 PMCID:PMC25813
|
| [16] |
Kavurma MM.ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes..J Cell Biochem2003;89:289-300
|
| [17] |
Kawauchi T,Nabeshima Y.The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration..EMBO J2003;22:4190-201 PMCID:PMC175802
|
| [18] |
Zhang L,Hayashi Y,Birk DE.A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure..EMBO J.2003;22:4443-54 PMCID:PMC202382
|
| [19] |
Berginski ME,Hahn KM.High-resolution quantification of focal adhesion spatiotemporal dynamics in living cells..PLoS One2011;6:e22025 PMCID:PMC3136503
|
| [20] |
Guo L,Xiao S.Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma..Life Sci2005;77:1869-78
|
| [21] |
Yin Y,Sun Y,Colburn NH.JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells..Biomed Pharmacother2009;63:429-35 PMCID:PMC3449307
|
| [22] |
Kappelmann M,Kuphal S.AP-1/c-Jun transcription factors: regulation and function in malignant melanoma..Eur J Cell Biol2014;93:76-81
|
| [23] |
Lee MH,Qu J.JNK phosphorylates beta-catenin and regulates adherens junctions..FASEB J2009;23:3874-83 PMCID:PMC2774999
|
| [24] |
Huang C,Borchers C,Jacobson K.JNK phosphorylates paxillin and regulates cell migration..Nature2003;424:219-23
|
| [25] |
Miyamoto Y,Yamamori N,Nagao M.Paxillin is the target of c-Jun N-terminal kinase in Schwann cells and regulates migration..Cell Signal2012;24:2061-9
|
| [26] |
Turner CE.Paxillin and focal adhesion signalling..Nat Cell Biol2000;2:E231-6
|
| [27] |
Turner CE.Paxillin interactions..J Cell Sci.2000;113 Pt 23:4139-40
|
| [28] |
Mitra SK.Integrin-regulated FAK-Src signaling in normal and cancer cells..Curr Opin Cell Biol2006;18:516-23
|
| [29] |
Zaidel-Bar R,Ma'ayan A,Geiger B.Functional atlas of the integrin adhesome..Nat Cell Biol2007;9:858-67 PMCID:PMC2735470
|
| [30] |
Huveneers S.Adhesion signal..J Cell Sci2009;122:1059-69
|
| [31] |
Harburger DS.Integrin signalling at a glance..J Cell Sci2009;122:159-63 PMCID:PMC2714413
|
| [32] |
Tumbarello DA,Turner CE.The paxillin LD motifs..FEBS Lett2002;513:114-8
|
| [33] |
Schaller MD.Paxillin: a focal adhesion-associated adaptor protein..Oncogene2001;20:6459-72
|
| [34] |
Brown MC.Paxillin: adapting to change..Physiol Rev2004;84:1315-39
|
| [35] |
Deakin NO.Paxillin comes of age..J Cell Sci2008;121:2435-44 PMCID:PMC2522309
|
| [36] |
Lopez-Colome AM,Benavides-Hidalgo R.Paxillin: a crossroad in pathological cell migration..J Hematol Oncol2017;10:50 PMCID:PMC5316197
|
| [37] |
Hammes SR,Sen A.Paxillin and steroid signaling: from frog to human..Methods Mol Biol2014;1204:95-108 PMCID:PMC5109017
|
| [38] |
Ma X.Paxillin actions in the nucleus..Steroids2018;133:87-92 PMCID:PMC5902031
|
| [39] |
Cai J,Wang H,Wang J.Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer..Oncotarget2017;8:74406-22 PMCID:PMC5650351
|
| [40] |
Chen J,Gallo KA.MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells..Oncogene2010;29:4399-411
|
| [41] |
Rattanasinchai C,Conrad SE.MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells..Oncogenesis2017;6:e345 PMCID:PMC5519193
|
| [42] |
Huigsloot M,Mulder GJ.Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells..J Biol Chem2002;277:35869-79
|
| [43] |
Xue C,Liang F,Violini S.Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis..Cancer Res2006;66:192-7
|
| [44] |
Vasanwala FH,Toney LM.Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene..J Immunol2002;169:1922-9
|
| [45] |
Chen EY,Kou Y,Wang Z.Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool..BMC Bioinformatics2013;14:128 PMCID:PMC3637064
|
| [46] |
Kuleshov MV,Rouillard AD,Duan Q.Enrichr: a comprehensive gene set enrichment analysis web server 2016 update..Nucleic Acids Res2016;44:W90-7 PMCID:PMC4987924
|
| [47] |
Rosse C,Boeckeler K,Kremerskothen J.An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation..PLoS Biol2009;7:e1000235 PMCID:PMC2762617
|
| [48] |
de Graauw M,Cramer R,Timms JF.Heat shock protein 27 is the major differentially phosphorylated protein involved in renal epithelial cellular stress response and controls focal adhesion organization and apoptosis..J Biol Chem2005;280:29885-98
|
| [49] |
Yamanaka I,Baba T,Suzuki T.Epidermal growth factor increased the expression of alpha2beta1-integrin and modulated integrin-mediated signaling in human cervical adenocarcinoma cells..Exp Cell Res2003;286:165-74
|
| [50] |
Ricono JM,Barnes LA,Weis SM.Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis..Cancer Res2009;69:1383-91 PMCID:PMC2741736
|
| [51] |
Lu Z,Blume-Jensen P.Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase..Mol Cell Biol2001;21:4016-31 PMCID:PMC87064
|
| [52] |
Thelemann A,Griffin G,Hunt T.Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells..Mol Cell Proteomics2005;4:356-76
|
| [53] |
Johnson AC,Matelis CM,Piebenga EC.Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression..Mol Med2000;6:17-27 PMCID:PMC1949911
|
| [54] |
Zenz R,Martin P,Eferl R.c-Jun regulates eyelid closure and skin tumor development through EGFR signaling..Dev Cell2003;4:879-89
|
| [55] |
Kimura K,Yamauchi J.Role of JNK-dependent serine phosphorylation of paxillin in migration of corneal epithelial cells during wound closure..Invest Ophthalmol Vis Sci2008;49:125-32
|
| [56] |
Ching YP,Lee MF,Jin DY.P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation..Cancer Res2007;67:3601-8
|
| [57] |
Smadja-Lamere N,Champagne C,Lavoie JN.JNK-mediated phosphorylation of paxillin in adhesion assembly and tension-induced cell death by the adenovirus death factor E4orf4..J Biol Chem2008;283:34352-64 PMCID:PMC2662241
|
| [58] |
Yamauchi J,Sanbe A.JNK phosphorylation of paxillin, acting through the Rac1 and Cdc42 signaling cascade, mediates neurite extension in N1E-115 cells..Exp Cell Res2006;312:2954-61
|
| [59] |
Rattanasinchai C,Conrad SE.MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells..Oncogenesis2017;6:e345 PMCID:PMC5519193
|
| [60] |
Kim DY.Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling..Oncogene2016;35:4495-508
|
| [61] |
Madshus IH.Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking..J Cell Sci2009;122:3433-9
|
| [62] |
Hess J,Schorpp-Kistner M.AP-1 subunits: quarrel and harmony among siblings..J Cell Sci2004;117:5965-73
|
| [63] |
Ishibe S,Zhu X.Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis..Mol Cell2003;12:1275-85
|
| [64] |
Ishibe S,Liu ZX.Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis..Mol Cell2004;16:257-67
|
| [65] |
Woods AJ,Choudhary J,Mazaki Y.Paxillin associates with poly(A)-binding protein 1 at the dense endoplasmic reticulum and the leading edge of migrating cells..J Biol Chem2002;277:6428-37
|
| [66] |
Lewis JM,Taagepera S,Wang JY.Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport..Proc Natl Acad Sci U S A.1996;93:15174-9 PMCID:PMC26376
|
| [67] |
Lewis JM.Integrins regulate the association and phosphorylation of paxillin by c-Abl..J Biol Chem1998;273:14225-30
|
| [68] |
Hervy M,Beckerle MC.From the membrane to the nucleus and back again: bifunctional focal adhesion proteins..Curr Opin Cell Biol2006;18:524-32
|
| [69] |
Sathe AR,Sheetz MP.Nuclear transport of paxillin depends on focal adhesion dynamics and FAT domains..J Cell Sci2016;129:1981-8 PMCID:PMC4895192
|
| [70] |
Sen A,DeFranco DB,Melamed J.Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation..J Clin Invest2012;122:2469-81 PMCID:PMC3386821
|
| [71] |
Wang Y.Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear..Biochim Biophys Acta2003;1593:115-20
|
| [72] |
Bubici C.JNK signalling in cancer: in need of new, smarter therapeutic targets..Br J Pharmacol2014;171:24-37 PMCID:PMC3874694
|
| [73] |
Kumar A,Kini SG,Agrawal S.JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases..Future Med Chem2015;7:2065-86
|